Ceramide: A contributor to insulin resistance or an innocent bystander?

Diabetologia

Volumn 51, Issue 7, 2008, Pages 1095-1096

  Boden, G ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Ceramide; Diacylglycerol; Inflammatory cytokines; Insulin receptor substrate 1 2; Insulin resistance; Liposyn II; Obesity; Protein kinase B Akt; Protein kinase C; Skeletal muscle

Indexed keywords

CERAMIDE; CYTOKINE; HEPARIN; LIPOPROTEIN LIPASE; PROTEIN KINASE B; TRIACYLGLYCEROL;

CELL MEMBRANE; CHRONIC INFLAMMATION; GLUCOSE TOLERANCE; GLYCOSYLATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

CERAMIDES; CYTOKINES; DIGLYCERIDES; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY;

EID: 44749091972     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-1015-y     Document Type: Note

References (12)

1. Wellen KE, Hotamisligil GS (2005) Inflammation, stress and diabetes. J Clin Invest 115:1111-1119
2. Unger RH (2003) Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159-5165
3. Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32:14-23
4. Boden G (2006) Obesity, insulin resistance, type 2 diabetes and free fatty acids. Expert Rev Endocrinol Metab 1:499-505
5. Yu C, Chen Y, Zong H et al (2002) Mechanisms by which fatty acids inhibit insulin activation of IRS-1 associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236
6. Summers SA (2006) Ceramide in insulin resistance and lipotoxicity. Prog Lipid Res 45:42-72
7. Skovbro M, Baranowski M, Skov-Jensen C et al. (2008) Human muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia. DOI 10.1007/s00125-008-1014-z
8. Straczkowski M, Kowalska I, Baranowski M et al (2007) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50:2366-2373
9. Adams JM, Pratipanawatr T, Berria R et al (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25-31
10. Ruvolo PP (2003) Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 47:383-392
11. Liu YY, Han TY, Giuliano AE, Hansen N, Cabot MC (2000) Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem 275:7138-7143
12. Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005-2011